Form 8-K - Current report:
SEC Accession No. 0001193125-20-202579
Filing Date
2020-07-29
Accepted
2020-07-29 16:34:54
Documents
35
Period of Report
2020-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d62323d8k.htm 8-K 28243
2 EX-99.1 d62323dex991.htm EX-99.1 6442
3 EX-99.2 d62323dex992.htm EX-99.2 54884
4 EX-99.3 d62323dex993.htm EX-99.3 37648
5 GRAPHIC g62323ex99_3s10g1.jpg GRAPHIC 502349
6 GRAPHIC g62323ex99_3s11g1.jpg GRAPHIC 410939
7 GRAPHIC g62323ex99_3s12g1.jpg GRAPHIC 378311
8 GRAPHIC g62323ex99_3s13g1.jpg GRAPHIC 505163
9 GRAPHIC g62323ex99_3s14g1.jpg GRAPHIC 511088
10 GRAPHIC g62323ex99_3s15g1.jpg GRAPHIC 283713
11 GRAPHIC g62323ex99_3s16g1.jpg GRAPHIC 516057
12 GRAPHIC g62323ex99_3s17g1.jpg GRAPHIC 508634
13 GRAPHIC g62323ex99_3s18g1.jpg GRAPHIC 439016
14 GRAPHIC g62323ex99_3s19g1.jpg GRAPHIC 537597
15 GRAPHIC g62323ex99_3s1g1.jpg GRAPHIC 416154
16 GRAPHIC g62323ex99_3s20g1.jpg GRAPHIC 600176
17 GRAPHIC g62323ex99_3s21g1.jpg GRAPHIC 310303
18 GRAPHIC g62323ex99_3s22g1.jpg GRAPHIC 474450
19 GRAPHIC g62323ex99_3s23g1.jpg GRAPHIC 405119
20 GRAPHIC g62323ex99_3s24g1.jpg GRAPHIC 533138
21 GRAPHIC g62323ex99_3s25g1.jpg GRAPHIC 375930
22 GRAPHIC g62323ex99_3s26g1.jpg GRAPHIC 484148
23 GRAPHIC g62323ex99_3s27g1.jpg GRAPHIC 330813
24 GRAPHIC g62323ex99_3s28g1.jpg GRAPHIC 533656
25 GRAPHIC g62323ex99_3s29g1.jpg GRAPHIC 394587
26 GRAPHIC g62323ex99_3s2g1.jpg GRAPHIC 716453
27 GRAPHIC g62323ex99_3s30g1.jpg GRAPHIC 319814
28 GRAPHIC g62323ex99_3s31g1.jpg GRAPHIC 190219
29 GRAPHIC g62323ex99_3s3g1.jpg GRAPHIC 608465
30 GRAPHIC g62323ex99_3s4g1.jpg GRAPHIC 235642
31 GRAPHIC g62323ex99_3s5g1.jpg GRAPHIC 535249
32 GRAPHIC g62323ex99_3s6g1.jpg GRAPHIC 375005
33 GRAPHIC g62323ex99_3s7g1.jpg GRAPHIC 520020
34 GRAPHIC g62323ex99_3s8g1.jpg GRAPHIC 441567
35 GRAPHIC g62323ex99_3s9g1.jpg GRAPHIC 267424
  Complete submission text file 0001193125-20-202579.txt   18948128
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 201057597
SIC: 2834 Pharmaceutical Preparations